Sandrine Desrayaud

1.4k total citations
38 papers, 1.1k citations indexed

About

Sandrine Desrayaud is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Sandrine Desrayaud has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in Sandrine Desrayaud's work include Neuroscience and Neuropharmacology Research (12 papers), Computational Drug Discovery Methods (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Sandrine Desrayaud is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Computational Drug Discovery Methods (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Sandrine Desrayaud collaborates with scholars based in Switzerland, France and Australia. Sandrine Desrayaud's co-authors include David A. Slattery, John F. Cryan, Ulf Neumann, Jean‐Michel Rondeau, Heinrich Rueeger, Rainer Machauer, Matthias Staufenbiel, Michel Lemaire, Jean‐Michel Scherrmann and Henrik Möbitz and has published in prestigious journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Sandrine Desrayaud

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by Sandrine Desrayaud

Since Specialization

Citations

This map shows the geographic impact of Sandrine Desrayaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Desrayaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Desrayaud more than expected).

Fields of papers citing papers by Sandrine Desrayaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Desrayaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Desrayaud. The network helps show where Sandrine Desrayaud may publish in the future.

Co-authorship network of co-authors of Sandrine Desrayaud

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Desrayaud. A scholar is included among the top collaborators of Sandrine Desrayaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Desrayaud. Sandrine Desrayaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DeepCt: Predicting Pharmacokinetic Concentration–Time Curves and Compartmental Models from Chemical Structure Using Deep Learning 2024 ·Molecular Pharmaceutics ·Maximilian Beckers, (unknown), Sandrine Desrayaud, Grégori Gerebtzoff, Raquel Rodríguez-Pérez	2
2	Improving In Vitro–In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules 2024 ·Drug Metabolism and Disposition ·(unknown), (unknown), Felix Huth, Birk Poller, Sandrine Desrayaud, Raquel Rodríguez-Pérez, Bernard Faller	2
3	Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945 2018 ·Acta Neuropathologica Communications ·Nicolau Beckmann, E. Giorgetti, (unknown), Stefan Zurbruegg, Nathalie Accart, Paul Smith, (unknown), Ludovic Perrot, Mark S. Nash, Sandrine Desrayaud, (unknown), Wilfried Frieauff, Derya R. Shimshek	92
4	Modulation of Oral Bioavailability and Metabolism for Closely Related Cyclic Hexapeptides 2017 ·International Journal of Peptide Research and Therapeutics ·Thomas Vorherr, Ian Lewis, Joerg Berghausen, Sandrine Desrayaud, Michael Schaefer	22
5	Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure 2016 ·ChemMedChem ·(unknown), Michael Schäfer, (unknown), Sandrine Desrayaud, Markus Blatter, Philippe Piéchon, Ina Dix, (unknown), Hans‐Jörg Roth	56
6	Pharmacokinetic Studies around the Mono‐ and Difunctionalization of a Bioavailable Cyclic Decapeptide Scaffold 2016 ·ChemMedChem ·(unknown), Michael Schäfer, Markus Blatter, (unknown), Sandrine Desrayaud, Hans‐Jörg Roth	24
7	Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urine 2015 ·Journal of Chromatography B ·Joachim Blanz, (unknown), David Pearson, (unknown), M. RITZAU, (unknown), (unknown), (unknown), Sandrine Desrayaud, Elisabeth Braun, Reiner Aichholz	6
8	Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Robin A. Fairhurst, Marc Gerspacher, Patricia Imbach‐Weese, Robert Mah, Giorgio Caravatti, Pascal Furet, Christine Fritsch, Christian Schnell, Joachim Blanz, Francesca Blasco, Sandrine Desrayaud, Daniel Guthy, Mark Knapp, (unknown), (unknown), (unknown), (unknown)	15
9	MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod) 2015 ·ChemMedChem ·Emmanuelle Briard, Bettina Rudolph, Sandrine Desrayaud, Joel A. Krauser, Yves P. Auberson	17
10	Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: Structure based design and in vivo reduction of amyloid β-peptides 2013 ·Bioorganic & Medicinal Chemistry Letters ·Heinrich Rueeger, (unknown), Rainer Machauer, (unknown), Laura H. Jacobson, Matthias Staufenbiel, Sandrine Desrayaud, Jean‐Michel Rondeau, Henrik Möbitz, Ulf Neumann	22
11	Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2 2013 ·Bioorganic & Medicinal Chemistry Letters ·Thomas Troxler, Paulette A. Greenidge, Kaspar Zimmermann, Sandrine Desrayaud, Peter Drückes, Tatjana Schweizer, Daniela Stauffer, Giorgio Rovelli, Derya R. Shimshek	31
12	Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease 2012 ·Journal of Neuroscience ·(unknown), Jennifer K. Truong, Kristofer E. Bouchard, (unknown), Sandrine Desrayaud, Saliha Moussaoui, Sarah J. Tabrizi, Nephi Stella, Paul J. Muchowski	109
13	6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·David Orain, Silvio Ofner, Manuel Koller, David A. Carcache, Wolfgang Froestl, Hans Allgeier, Vittorio Rasetti, Joachim Nozulak, Henri Mattes, Nicolas Soldermann, Philipp Floersheim, Sandrine Desrayaud, Joerg Kallen, Kurt Lingenhoehl, Stephan Urwyler	16
14	Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Heinrich Rueeger, Jean‐Michel Rondeau, Clive McCarthy, Henrik Möbitz, Marina Tintelnot‐Blomley, Ulf Neumann, Sandrine Desrayaud	32
15	Macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors with activity in vivo 2009 ·Bioorganic & Medicinal Chemistry Letters ·Rainer Machauer, Kurt Laumen, Siem J. Veenstra, Jean‐Michel Rondeau, Marina Tintelnot‐Blomley, Claudia Betschart, Anne-Lise Jaton, Sandrine Desrayaud, Matthias Staufenbiel, (unknown), Paolo Paganetti, Ulf Neumann	44
16	The positive allosteric modulator GS39783 enhances GABA_B receptor‐mediated inhibition of cyclic AMP formation in rat striatum in vivo 2006 ·Journal of Neurochemistry ·(unknown), Sandrine Desrayaud, Stefan Imobersteg, Stephan Urwyler	24
17	Hyperdopaminergia and altered locomotor activity in GABA_B1‐deficient mice 2006 ·Journal of Neurochemistry ·Claire‐Marie Vacher, Martin Gassmann, Sandrine Desrayaud, Étienne Challet, Amyaouch Bradaïa, Daniël Hoyer, P. C. Waldmeier, Klemens Kaupmann, Paul Pévet, Bernhard Bettler	38
18	GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent 2004 ·Journal of Pharmacology and Experimental Therapeutics ·David A. Slattery, Sandrine Desrayaud, John F. Cryan	106
19	Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine 1997 ·Life Sciences ·Sandrine Desrayaud, (unknown), Jean‐Michel Scherrmann, Michel Lemaire	49
20	Dose-dependent delivery of colchicine to the rat hippocampus by microdialysis 1996 ·Neuroscience Letters ·Sandrine Desrayaud, G Boschi, Richard Rips, Jean‐Michel Scherrmann	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact